CCNA2 and non-Hodgkin lymphoma: The Ki-67 immunoreactivity (cell proliferation) seen among BL, NHL and HD cases at MNH is comparable with that in other reports [42,43] but the value of such proliferation markers like Ki-67 and cyclin-A (Cy-A) as prognostic indicators in Tanzania needs extended studies.